Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2010, Article ID 143540, 7 pages
http://dx.doi.org/10.1155/2010/143540
Clinical Study

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas

1Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA
2Division of Medical Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA
3Department of Orthopedic Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA
4Department of Radiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA
5Department of Pathology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA
6Abteilung Nuklearmedizin, University of Freiburg, 79106 Freiburg, Germany
7Division of Surgical Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA

Received 2 September 2009; Revised 18 December 2009; Accepted 8 February 2010

Academic Editor: Marcus Schlemmer

Copyright © 2010 Matthias R. Benz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Matthias R. Benz, Johannes Czernin, William D. Tap, et al., “FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas,” Sarcoma, vol. 2010, Article ID 143540, 7 pages, 2010. https://doi.org/10.1155/2010/143540.